Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 474601 - 474620 out of 483426 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L01EX12) larotrectinib (adm: O) | VITRAKVI 20MG/ML SOLN,ORAL | 2x50ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Abdominal Neoplasms | BayerHealthCarePharmaceuticals,Inc. |
| USA | (L01EX12) larotrectinib (adm: O) | VITRAKVI 100MG CAP | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Abdominal Neoplasms | BayerHealthCarePharmaceuticals,Inc. |
| USA | (L01EX12) larotrectinib (adm: O) | VITRAKVI 100MG CAP | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Abdominal Neoplasms | BayerHealthCarePharmaceuticals,Inc. |
| USA | (L01EX12) larotrectinib (adm: O) | VITRAKVI 25MG CAP | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Abdominal Neoplasms | BayerHealthCarePharmaceuticals,Inc. |
| USA | (L01EX12) larotrectinib (adm: O) | VITRAKVI 25MG CAP | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Abdominal Neoplasms | BayerHealthCarePharmaceuticals,Inc. |
| USA | (L01EX13) gilteritinib (adm: O) | XOSPATA 40MG TAB | 90 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid, Acute | AstellasPharmaU.S.,Inc. |
| USA | (L01EX14) entrectinib (adm: O) | ROZLYTREK 100MG CAPSULE | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Cancer;Carcinoma, Non-Small-Cell Lung | GenentechUSA,Inc. |
| USA | (L01EX14) entrectinib (adm: O) | ROZLYTREK 100MG CAPSULE | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Cancer;Carcinoma, Non-Small-Cell Lung | GenentechUSA,Inc. |
| USA | (L01EX14) entrectinib (adm: O) | ROZLYTREK 200MG CAPSULE | 90 | Ex-factory price without vat |
$0-0 |
$0-0 |
Cancer;Carcinoma, Non-Small-Cell Lung | GenentechUSA,Inc. |
| USA | (L01EX14) entrectinib (adm: O) | ROZLYTREK 200MG CAPSULE | 90 | Ex-factory price without vat |
$0-0 |
$0-0 |
Cancer;Carcinoma, Non-Small-Cell Lung | GenentechUSA,Inc. |
| USA | (L01EX14) entrectinib (adm: O) | ROZLYTREK 50MG PELLET PKT | 42 | Ex-factory price without vat |
$0-0 |
$0-0 |
Cancer;Carcinoma, Non-Small-Cell Lung | GenentechUSA,Inc. |
| USA | (L01EX14) entrectinib (adm: O) | ROZLYTREK 50MG PELLET PKT | 42 | Ex-factory price without vat |
$0-0 |
$0-0 |
Cancer;Carcinoma, Non-Small-Cell Lung | GenentechUSA,Inc. |
| USA | (L01EX15) pexidartinib (adm: O) | TURALIO 125MG CAP,ORAL | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | DaiichiSankyo,Inc. |
| USA | (L01EX15) pexidartinib (adm: O) | TURALIO 125MG CAP,ORAL | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | DaiichiSankyo,Inc. |
| USA | (L01EX17) capmatinib (adm: O) | TABRECTA 150MG TAB | 56 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | NovartisPharmaceuticalsCorporation |
| USA | (L01EX17) capmatinib (adm: O) | TABRECTA 150MG TAB | 56 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | NovartisPharmaceuticalsCorporation |
| USA | (L01EX17) capmatinib (adm: O) | TABRECTA 200MG TAB | 56 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | NovartisPharmaceuticalsCorporation |
| USA | (L01EX17) capmatinib (adm: O) | TABRECTA 200MG TAB | 56 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | NovartisPharmaceuticalsCorporation |
| USA | (L01EX18) avapritinib (adm: O) | AYVAKIT 100MG | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BlueprintMedicines,Corporation |
| USA | (L01EX18) avapritinib (adm: O) | AYVAKIT 100MG | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BlueprintMedicines,Corporation |
Pages
